Does one week of 10mg vs. 40mg Rosuvastatin improve skin microvascular blood flow in stable non-ST segment elevation myocardial infarction (NSTEMI) and healthy controls? A pilot study.
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2019
Price : $35 *
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes; Arteriosclerosis; Cardiovascular disorders; Heart failure; Hypercholesterolaemia; Hyperlipidaemia; Myocardial infarction; Stroke
- Focus Pharmacodynamics
- 24 Mar 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 08 Jun 2016 Planned initiation date changed from 1 Jul 2013 to 1 Jan 2016.
- 14 Aug 2013 New trial record